2023
DOI: 10.1016/j.ejim.2023.06.020
|View full text |Cite
|
Sign up to set email alerts
|

Multiple autoimmune syndrome: Clinical, immunological and genotypic characterization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 70 publications
0
0
0
Order By: Relevance
“…proposed the genetic background hypothesis, highlighting the HLA-DRB1*03 gene as a significant risk factor [14]. In patients with MAS, it is common to have at least one dermatological condition, usually vitiligo or alopecia areata.…”
Section: Discussionmentioning
confidence: 99%
“…proposed the genetic background hypothesis, highlighting the HLA-DRB1*03 gene as a significant risk factor [14]. In patients with MAS, it is common to have at least one dermatological condition, usually vitiligo or alopecia areata.…”
Section: Discussionmentioning
confidence: 99%
“…The mosaic of autoimmunity exhibits multi-factorial origin, and the diversity of autoimmune disease (AD) expression is frequently identified using classification criteria. They have sub-phenotypic similarities, such as signs and symptoms, non-specific autoantibodies, and other immunological alterations that are subject to categorization issues [ 2 ]. One of the strongest arguments supporting autoimmune tautology is polyautoimmunity, defined as the presence of two or more ADs in a single patient.…”
Section: Introductionmentioning
confidence: 99%
“…Some researchers believe that the presence of polyautoimmunity exacerbates the manifestation of a specific AD, leading to a more severe clinical outcome, whereas others believe that it does not exert any substantial influence or may, in fact, result in a more favorable prognosis for individuals with ADs. Due to their chronic nature, these ADs place a substantial strain on both social and medical resources, while also affecting the overall quality of life [ 2 ]. The capacity to diagnose the onset of these illnesses in the pre-symptomatic phase and to forecast their progression would mark a significant advancement in primary, secondary, and tertiary prevention [ 1 ].…”
Section: Introductionmentioning
confidence: 99%